← Leaderboards
Thomas J. Meade
California Institute Of Technology
$11,533,097
Attributed
$15,816,632
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$15,816,632 · 16
By mechanism
R01$12,233,086 · 6
U54$1,696,276 · 2
P30$506,097 · 1
P50$464,479 · 1
R21$362,935 · 1
R56$316,125 · 1
Top collaborators
- Miguel S Esteves5 shared
- Heather L Gray-Edwards5 shared
- Douglas R Martin5 shared
- Bulent Aydogan4 shared
- James Peter Basilion4 shared
- Joanna E Burdette2 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCellsMagnetic Resonance ImagingImageContrast MediaDesignResearch PersonnelMalignant NeoplasmsToxic EffectMolecularIn VitroAnimal ModelStructureBasePropertyTechnologyMonitorTumorTissuesModalityBiologicalComplexCollaborationsGene Expression
Grant awards (59)
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization$631,513
R01 · FY2024 · CA
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$548,624
R01 · FY2024 · NS · contact PI
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$659,071
R01 · FY2023 · NS · contact PI
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization$651,717
R01 · FY2023 · CA
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$655,861
R01 · FY2022 · NS · contact PI
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization$647,930
R01 · FY2022 · CA
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization$691,313
R01 · FY2021 · CA
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$645,047
R01 · FY2021 · NS · contact PI
Real-Time Tracking of Gene Therapy by Bioactivated MR contrast Probes$629,733
R01 · FY2020 · NS · contact PI
Specific inhibition of transcription factors with Cobalt-Schiff Base Complexes$293,567
R01 · FY2020 · GM · contact PI
Molecular and Translational Imaging Core Facility Shared Resource$159,640
P30 · FY2020 · CA · contact PI
Imaging in 2020: Imaging in Immuno-oncology (I3O)$8,000
R13 · FY2020 · CA · contact PI
Specific inhibition of transcription factors with Cobalt-Schiff Base Complexes$293,567
R01 · FY2019 · GM · contact PI
Molecular and Translational Imaging Core Facility Shared Resource$159,640
P30 · FY2019 · CA · contact PI
Specific inhibition of transcription factors with Cobalt-Schiff Base Complexes$293,567
R01 · FY2018 · GM · contact PI
Molecular and Translational Imaging Core Facility Shared Resource$162,811
P30 · FY2018 · CA · contact PI
Molecular and Translational Imaging Core Facility Shared Resource$8,621
P30 · FY2018 · CA · contact PI
Molecular and Translational Imaging Core Facility Shared Resource$8,489
P30 · FY2018 · CA · contact PI
Molecular and Translational Imaging Core Facility Shared Resource$6,896
P30 · FY2018 · CA · contact PI
Imaging in 2020: Visualizing the Future of Health Care with MR Imaging$5,000
R13 · FY2018 · CA · contact PI
Specific inhibition of transcription factors with Cobalt-Schiff Base Complexes$311,047
R01 · FY2017 · GM · contact PI
Imaging in 2020-VIII: Integrating Molecular Imaging and Complex Biology$7,000
R13 · FY2016 · CA · contact PI
Steroid-Based Contrast Agents for Magnetic Resonance Imaging of Endocrine Disease$336,526
R01 · FY2015 · EB · contact PI
Imaging in 2020-VIII: Integrating Molecular Imaging and Complex Biology$1
R13 · FY2015 · CA · contact PI
Steroid-Based Contrast Agents for Magnetic Resonance Imaging of Endocrine Disease$333,418
R01 · FY2014 · EB · contact PI
Theranostic Magnetic Nanostructures for the Molecular Imaging of Cancer$172,448
U54 · FY2014 · CA · contact PI
Co(III) Schiff base complexes as selective and irreversible inhibitors of MMP-2$74,933
R03 · FY2014 · CA · contact PI
Imaging in 2020-VIII: Integrating Molecular Imaging and Complex Biology$3,000
R13 · FY2014 · CA · contact PI
Steroid-Based Contrast Agents for Magnetic Resonance Imaging of Endocrine Disease$324,439
R01 · FY2013 · EB · contact PI
q-Modulated Magnetic Resonance Imaging Contrast Agents$295,247
R01 · FY2013 · EB · contact PI
Theranostic Magnetic Nanostructures for the Molecular Imaging of Cancer$164,754
U54 · FY2013 · CA · contact PI
Co(III) Schiff base complexes as selective and irreversible inhibitors of MMP-2$77,250
R03 · FY2013 · CA · contact PI
Theranostic Magnetic Nanostructures for the Molecular Imaging of Cancer$5,396
U54 · FY2013 · CA · contact PI
Steroid-Based Contrast Agents for Magnetic Resonance Imaging of Endocrine Disease$356,617
R01 · FY2012 · EB · contact PI
q-Modulated Magnetic Resonance Imaging Contrast Agents$313,888
R01 · FY2012 · EB · contact PI
Theranostic Magnetic Nanostructures for the Molecular Imaging of Cancer$216,033
U54 · FY2012 · CA · contact PI
Imaging in 2020-VIII: Integrating Molecular Imaging and Complex Biology$52,450
R13 · FY2012 · CA · contact PI
q-Modulated Magnetic Resonance Imaging Contrast Agents$314,647
R01 · FY2011 · EB · contact PI
Theranostic Magnetic Nanostructures for the Molecular Imaging of Cancer$191,674
U54 · FY2011 · CA · contact PI
Progesterone Contrast Agents for MRI$188,438
R21 · FY2011 · CA · contact PI
Imaging in 2020-7: Bridging Molecular Imaging and Therapy$10,000
R13 · FY2011 · CA · contact PI
q-Modulated Magnetic Resonance Imaging Contrast Agents$328,100
R01 · FY2010 · EB · contact PI
Theranostic Magnetic Nanostructures for the Molecular Imaging of Cancer$196,951
U54 · FY2010 · CA · contact PI
Progesterone Contrast Agents for MRI$174,497
R21 · FY2010 · CA · contact PI
Bioactivated Nanoprobes for Molecular imaging of cancer$446,584
U54 · FY2009 · CA · contact PI
q-Modulated Magnetic Resonance Imaging Contrast Agents$316,125
R56 · FY2009 · EB · contact PI
Bioactivated Nanoprobes for Molecular imaging of cancer$302,436
U54 · FY2008 · CA · contact PI
q-Modulated Magnetic Resonance Contrast Agents$237,710
R01 · FY2008 · EB · contact PI
Magnetic Resonance Imaging Core$124,084
P50 · FY2008 · NS · contact PI
q-Modulated Magnetic Resonance Contrast Agents$240,161
R01 · FY2007 · EB · contact PI
Magnetic Resonance Imaging Core$127,112
P50 · FY2007 · NS · contact PI
q-Modulated Magnetic Resonance Contrast Agents$247,968
R01 · FY2006 · EB · contact PI
Magnetic Resonance Imaging Core$101,510
P50 · FY2006 · NS · contact PI
q-Modulated Magnetic Resonance Contrast Agents$245,826
R01 · FY2005 · EB
Magnetic Resonance Imaging Core$111,773
P50 · FY2005 · NS
NEW CONTRAST AGENTS FOR MR IMAGING OF THE IMMUME SYSTEM$387,683
R01 · FY2003 · AI
NEW CONTRAST AGENTS FOR MR IMAGING OF THE IMMUME SYSTEM$401,899
R01 · FY2002 · AI
NEW CONTRAST AGENTS FOR MR IMAGING OF THE IMMUME SYSTEM$429,000
R01 · FY2001 · AI
NEW CONTRAST AGENTS FOR MR IMAGING OF THE IMMUME SYSTEM$487,400
R01 · FY2000 · AI